PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
Authors:
- John GodtfredsenJGJohn Godtfredsen
- Gudrun BoysenGBGudrun Boysen
- EllenD AndersenEAEllenD Andersen
- Bjørn AndersenBABjørn Andersen
- 1 January 1989
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 333 (8631) , 175-179
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stroke incidence and risk factors for stroke in Copenhagen, Denmark.Stroke, 1988
- Aspirin for the Primary Prevention of Myocardial InfarctionNew England Journal of Medicine, 1988
- Silent cerebral infarction in chronic atrial fibrillation.Stroke, 1987
- The Natural History of Lone Atrial FibrillationNew England Journal of Medicine, 1987
- Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillationAmerican Heart Journal, 1986
- Embolic complications in paroxysmal atrial fibrillation.Stroke, 1986
- Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.Stroke, 1986
- Duration of atrial fibrillation and imminence of stroke: the Framingham study.Stroke, 1983
- Atrial Fibrillation RevisitedNew England Journal of Medicine, 1982
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967